The U.S. Supreme Court’s decision in Harrington v. Purdue Pharma LP2 has, in many respects, changed the landscape for nonconsensual third-party releases in chapter 11 cases. What effect, if any, has Purdue had on the viability of such releases in chapter 15 cases? As two recent decisions suggest, perhaps not much, and those decisions provide far more flexibility for nonconsensual third-party releases in chapter 15 than the Supreme Court allows in chapter 11.
Originally published in The American Bankruptcy Institute Journal - October 2025.
Please see full publication below for more information.
